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Conclusion: We conclude that not only sufficient number of 
MSCs can be isolated from patients over 65 years of age but that 
the differentiation capability of these cells is equal to that of young 
patients. Therefore, a cartilage tissue engineering approach for 
the treatment of OA-lesions in the elderly populaton based on a 
therapeutic application of MSCs seems feasible. 
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Lubricin, also commonly referred to as superficial zone protein 
(SZP) and proteoglycan 4 (PRG4) is a mucinous sialoglycopro- 
tein required for critical boundary lubrication at interfacing sur- 
faces of cartilage and other joint tissues, enabling low friction lev- 
els. 
Aim of study: To investigate alterations in lubricin expres- 
sion/metabolism that occur in vivo during the progression of os- 
teoarthritis (OA), and to determine if lubricin degradation occurs 
in OA synovial fluids. In addition, ex vivo alterations in soluble 
and cartilage-associated lubricin expression were assessed after 
the exposure of cartilage explants to inflammatory and catabolic 
mediators. 
Methods: Sections of human articular cartilage (non-OA, mild- 
lesional OA and severe-lesional/fibrillated OA) were immunos- 
tained with Ab 06A10, raised against recombinant human lubricin 
(rHu-lubricin) Met 1 -Leu 924, and also with a panel of anti-peptide 
antibodies directed to specific domains of the lubricin molecule. 
Purified full length rHu-lubricin was labeled by biotinylation of 
sialic acid residues following periodate oxidation, and incubated 
for 24h at 37°C with recombinant MMPs, ADAMTSs, or samples 
of human OA synovial fluid (SF). Biotinylated lubricin (bLub) was 
separated by SDS-PAGE and detected by affinity blotting with 
streptavidin-HRR Calf articular cartilage explants were cultured 
in the presence of ascorbic acid in the absence or presence of cy- 
toregulatory factors. Conditioned media was fractionated on hep- 
arin sepharose, and cartilage surface-associated lubricin was ex- 
tracted from the explants by extraction with 1.5M NaCI at 4°C for 
16h. Samples were analyzed by Western blotting with MAb 6-A-1. 
Results: Whereas lubricin immunolocalized to a discrete sur- 
face layer in non-OA cartilage, 'misexpression' of lubricin in 
deeper zones was evident in OA tissue, particularly around chon- 
drocytes. Full length and truncated lubricin isoforms were de- 
tected in human OA synovial fluids, and incubation of bLub with 
human OA SFs resulted in lubricin degradation. Inclusion of 
EDTA (but not PMSF, 6-AHA or benzamidine-HCI) was shown to 
prevent metalloproteinase-mediated lubricin degradation by OA 
SFs. Catabolism of bLub was observed following incubation with 
MMPs in vitro. Stimulation of calf articular cartilage explant cul- 
tures with IL-lb, TGFb, TNFa, retinoic acid or oncostatin M in- 
duced quantitative and/or structural alterations in the expression 
of lubricin at the cartilage surface, and changes were also appar- 
ent in explant conditioned media. 
Conclusions: The current studies demonstrate that quantitative 
and/or qualitative alterations of cartilage and synovial fluid lu- 
bricin occur during OA, and it is apparent hat metalloproteinase 
activity in osteoarthritic synovial fluid may contribute to lubricin 
deficiency. In addition, proinflammatory cytokines such as IL-1 
and TNFa may engender a deficit of full-length lubricin associ- 
ated with cartilage surfaces. 
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Aims: The chemokine family of secreted proteins regulates 
cellular activities through interaction with G protein-coupled 
chemokine receptors. We have shown previously that the con- 
centration of a chemokine stromal cell derived factor-1 (SDF-1) 
in synovial fluid from rheumatoid arthritic or osteoarthritic patients 
is greatly increased, which results in a stimulation of matrix met- 
alloproteinase (MMP) 3 releases from articular chondrocytes. In 
this study, we test whether the binding of SDF-1 to its recep- 
tor CXCR4 in chondrocytes induces cartilage matrix degradation, 
and if so, whether we can inhibit this process by down-regulating 
CXCR4 with Small Interfering RNA (SiRNA). 
Method: Articular cartilage or chondrocytes were incubated with 
SDF-1 (250 ng/ml). Chondrocytes were transfected with PU61- 
CXCR4 vector containing SiRNA targeting endogenous CXCR4, 
or empty vector PU61, before SDF-1 treatment. The release of 
the sulfated-glycosaminoglycans (GAG) in the culture medium 
was quantified by DMMB assay, while distribution of proteogly- 
can in cartilage was examined by safranin-O staining. The activi- 
ties of MMPs in culture medium were quantified by ELISA, while 
the mRNA levels of MMP-13 and TIMP1 were determined by RT- 
PCR. 
Result: Treatment of human articular chondrocytes with SDF-1 
induced the mRNA level of MMP-13, increased MMP-13 activi- 
ties, and inhibited the mRNA level of TIMP1. Transfecting chon- 
drocytes with CXCR4 SiRNA knocked down the endogenous lev- 
els of both SDF-1 receptor CXCR4 mRNA and protein in chon- 
drocytes. These CXCR4 SiRNA transfected chondrocytes were 
resistant not only to the SDF-1 induction of MMP-13 mRNA level, 
but also to the SDF-1 inhibition of TIMP1 mRNA level. Incubation 
of human articular cartilage with SDF-1 for 4 days significantly 
induced matrix degradation including enlarged and sometimes 
empty lacunae, decrease of cell number, and the decrease of 
proteoglycan (PG) staining. Fissures were observed in the su- 
perficial ayer of cartilage represented by tunnels extending from 
empty lacunae to the surface of cartilage. Incubation of articular 
cartilage with a monoclonal antibody against CXCR4 before SDF- 
1 treatment inhibited SDF-1 induced cartilage matrix degradation 
and fissure formation. 
Conclusions: Knocking down the protein level of SDF-1 recep- 
tor CXCR4 in chondrocytes by SiRNA abolished SDF-1 induced 
catabolic effects, while a CXCR4 neutralizing antibody prevented 
SDF-1 induced cartilage matrix degradation. Thus, blocking SDF- 
1 interaction with its receptor CXCR4 may be applicable to 
developing chondro-protective therapy to treat pro-inflammatory 
chemokine induced arthritis. 
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Objective: Toll-like receptors (TLRs) are evolutionary conserved 
receptors of the innate immunity-system. Bacterial cell wall com- 
ponents e.g. LPS bind to specific TLRs and may be play a role in 
